Tinea Corporis and Concomitance of Rosacea Triggered By Systemic Steroid Treatment
dc.authorid | Albayrak, Hulya/0000-0002-2022-578X | |
dc.contributor.author | Erdem, Havva | |
dc.contributor.author | Guvenc, Serdar Cenk | |
dc.contributor.author | Albayrak, Hulya | |
dc.contributor.author | Yanik, M. Emin | |
dc.contributor.author | Gurlevik, Zehra | |
dc.date.accessioned | 2024-09-25T19:59:57Z | |
dc.date.available | 2024-09-25T19:59:57Z | |
dc.date.issued | 2011 | |
dc.department | Abant İzzet Baysal Üniversitesi | en_US |
dc.description.abstract | Tinea corporis is a superficial dermatophyte infection characterized by either inflammatory or noninflammatory lesions on the glabrous skin (ie, skin regions except the scalp, groin, palms, and soles). Rosacea is a common inflammatory disease in which numerous etiologic and triggering factors play a role, and characterized with flushing episodes, telangiectasias, and recurrent inflammatory papules and pustules. Herein, we report a case of concomitance of rosacea triggered by systemic steroid treatment and tinea corporis with atypic clinic presentation. | en_US |
dc.identifier.endpage | 25 | en_US |
dc.identifier.issn | 1309-3878 | |
dc.identifier.issue | 3 | en_US |
dc.identifier.startpage | 22 | en_US |
dc.identifier.uri | https://hdl.handle.net/20.500.12491/13994 | |
dc.identifier.volume | 3 | en_US |
dc.identifier.wos | WOS:000420936400005 | en_US |
dc.identifier.wosquality | N/A | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | tr | en_US |
dc.publisher | Duzce Univ | en_US |
dc.relation.ispartof | Konuralp Tip Dergisi | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.snmz | YK_20240925 | en_US |
dc.subject | Rosacea | en_US |
dc.subject | tinea corporis | en_US |
dc.subject | steroid | en_US |
dc.title | Tinea Corporis and Concomitance of Rosacea Triggered By Systemic Steroid Treatment | en_US |
dc.type | Article | en_US |